中国临床新医学
中國臨床新醫學
중국림상신의학
CHINESE JOURNAL OF NEW CLINICAL MEDICINE
2013年
12期
1163-1166
,共4页
陈峰松%邢卫松%王松柳%赵建妹
陳峰鬆%邢衛鬆%王鬆柳%趙建妹
진봉송%형위송%왕송류%조건매
肝硬化%肝硬化心肌病%前脑利钠肽%心电图
肝硬化%肝硬化心肌病%前腦利鈉肽%心電圖
간경화%간경화심기병%전뇌리납태%심전도
Liver cirrhosis ( LC )%Cirrhotic cardiomyopathy ( CCM )%Pro B-type natriuretic peptide (proBNP)%Electrocardiogram(ECG)
目的:探讨血浆前脑利钠肽(proBNP)对肝硬化心肌病的判断价值。方法对38例肝硬化患者( LC组)和20名健康体检者( CG 组),用ELISA法测定血浆proBNP水平,并行心电图检查。比较两组proBNP水平及心电图改变( QTc、QTd、QTcd和Pd)的差异;对肝硬化患者,分析心电图改变与 CTP 积分、MELD评分、proBNP的关系。结果 LC组proBNP水平为(228.0±83.4) fmol/ml,显著高于CG组(127.4±21.1)fmol/ml。 LC组QTc、QTd、QTcd、Pd分别为(446.9±28.0)ms1/2、(36.4±6.6)ms、(40.6±9.0)ms1/2、(22.8±4.8)ms,均显著长于CG组(417.2±21.5)ms1/2、(29.6±4.9)ms、(31.1±4.9)ms1/2、(19.0±4.1)ms,且与CTP、MELD、proBNP水平呈正相关。结论肝硬化患者存在心肌受损,血浆proBNP可较好地反映肝硬化心肌病病情。
目的:探討血漿前腦利鈉肽(proBNP)對肝硬化心肌病的判斷價值。方法對38例肝硬化患者( LC組)和20名健康體檢者( CG 組),用ELISA法測定血漿proBNP水平,併行心電圖檢查。比較兩組proBNP水平及心電圖改變( QTc、QTd、QTcd和Pd)的差異;對肝硬化患者,分析心電圖改變與 CTP 積分、MELD評分、proBNP的關繫。結果 LC組proBNP水平為(228.0±83.4) fmol/ml,顯著高于CG組(127.4±21.1)fmol/ml。 LC組QTc、QTd、QTcd、Pd分彆為(446.9±28.0)ms1/2、(36.4±6.6)ms、(40.6±9.0)ms1/2、(22.8±4.8)ms,均顯著長于CG組(417.2±21.5)ms1/2、(29.6±4.9)ms、(31.1±4.9)ms1/2、(19.0±4.1)ms,且與CTP、MELD、proBNP水平呈正相關。結論肝硬化患者存在心肌受損,血漿proBNP可較好地反映肝硬化心肌病病情。
목적:탐토혈장전뇌리납태(proBNP)대간경화심기병적판단개치。방법대38례간경화환자( LC조)화20명건강체검자( CG 조),용ELISA법측정혈장proBNP수평,병행심전도검사。비교량조proBNP수평급심전도개변( QTc、QTd、QTcd화Pd)적차이;대간경화환자,분석심전도개변여 CTP 적분、MELD평분、proBNP적관계。결과 LC조proBNP수평위(228.0±83.4) fmol/ml,현저고우CG조(127.4±21.1)fmol/ml。 LC조QTc、QTd、QTcd、Pd분별위(446.9±28.0)ms1/2、(36.4±6.6)ms、(40.6±9.0)ms1/2、(22.8±4.8)ms,균현저장우CG조(417.2±21.5)ms1/2、(29.6±4.9)ms、(31.1±4.9)ms1/2、(19.0±4.1)ms,차여CTP、MELD、proBNP수평정정상관。결론간경화환자존재심기수손,혈장proBNP가교호지반영간경화심기병병정。
Objective To investigate the value of plasma pro B-type natriuretic peptide level in diagnosis of cirrhotic cardiomyopathy(CCM).Methods Plasma proBNP levels,the changes on ECG(QTc,QTd,QTcd and Pd) were measured and evaluated in 38 patients with cirrhosis and 20 healthy controls , and compared between the two groups.In patients with cirrhosis , the association between the changes on ECG and CTP score ,MELD score,proBNP levels were analyzed .Results ProBNP was significantly higher in patients with cirrhosis ( 228.0 ±83.4 ) fmol/ml than in healthy controls(127.4 ±21.1 )fmol/ml.And in patients with cirrhosis,the changes on ECG, QTc、QTd, QTcd and Pd, were (446.9 ±28.0)ms1/2,(36.4 ±6.6)ms,(40.6 ±9.0)ms1/2,(22.8 ±4.8)ms respectively and significantly increased compared with healthy subjects (417.2 ±21.5)ms1/2,(29.6 ±4.9)ms,(31.1 ±4.9)ms1/2, (19.0 ±4.1)ms, and positively related to CTP score,MELD score and proBNP level.Conclusion The plasma level of proBNP was valuable for diagnosis of CCM ,and correlated with the severity of CCM .